News

Editor of Pharmaceutical Technology Europe

Articles

Waters Corporation expected to boost growth in bioanalytical characterization for new modalities with acquisition of Wyatt Technology.

Waters Set for Growth in Bioanalytical Characterization with Wyatt Acquisition

Grant Playter is the Assistant Editor for 

In a brief, the Federal Trade Commission cited concerns about the acquisition resulting in an increased monopoly on Amgen’s newly acquired thyroid eye disease and chronic refractory gout treatments.

FTC Sues to Block Amgen’s $27.8 Billion Acquisition of Horizon Therapeutics

Private investors from Advent International and Warburg Pincus will operate the assets as an independent CDMO.

Baxter Divests BioPharma Solutions Department in $4.25 Billion Deal

Merck will acquire Prometheus Biosciences, a clinical-stage biotechnology company specializing in immune-mediated diseases, at a total equity valuation of $10.8 billion.

Merck to Purchase Prometheus Biosciences for $10.8 Billion

Sartorius’ acquisition of Polyplus is designed to strengthen its cell and gene therapy capabilities.

Sartorius to Acquire Polyplus in $2.6 Billion Deal

The Supreme Court heard oral arguments concerning the legitimacy of “genus clauses” in bio/pharma patents.

US Supreme Court Weighs Biologics Patents in Amgen vs. Sanofi Case

Narcan, from Emergent Solutions, will be the first naloxone product permitted for use without prescription by FDA.

FDA Approves First Over-the-Counter Naloxone Nasal Spray

Pfizer will acquire all outstanding shares of Seagen for a total of $43 billion.

Pfizer to Acquire Seagen in $43 Billion Blockbuster Deal

Sumitovant Bipharma has completed its acquisition of Myovant Sciences for approximately $1.7 billion.

Sumitovant Acquires Myovant for $1.7 Billion

Silicon Valley Bank has collapsed, leaving many biotechnology companies unsure of the future. 

Top News